These Stocks Are Today’s Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More - Barron's

Assessing Immatics (NasdaqCM:IMTX) Valuation After Earnings Loss And Pipeline And Moderna Updates - simplywall.st

Patent Truce on mRNA Delivery Might Change The Case For Investing In Moderna (MRNA) - simplywall.st

Is Moderna (MRNA) Pricing Too High After Its Recent 70% Year To Date Rally - Yahoo Finance

Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook - Yahoo Finance

FDA vaccine head will step down in April after string of controversial decisions

Moderna Stock (MRNA) Opinions on FDA Vaccines Chief Departure - Quiver Quantitative

FDA's abrupt flip‑flop on Moderna's mRNA flu shot highlights growing risks to drugmakers of investing in vaccines - PhillyVoice

Retail Surge: Will Tidal Trust II YieldMax MRNA stock justify high valuation - 2025 Key Highlights & Smart Swing Trading Techniques - Naître et grandir

Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica

Novo Nordisk is still Deeply Undervalued

Moderna Pops As FDA's Controversial Vaccine Lead Plans Exit - Investor's Business Daily

Biggest stock movers Wednesday: Crypto stocks, Wix, MRNA, and more - MSN

Hung Trinh: Moderna Reaches $2.25B Settlement in mRNA Vaccine Patent Dispute - Oncodaily

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - TradingView

Weekly Rundown: Moderna agrees to record settlement over COVID vaccine patents - Drug Discovery News

Portfolio got a quick shot in the arm today. (500x $MRNA $52C)

EMA Panel Backs Moderna's COVID-Flu Shot, Sanofi's Sleeping Sickness Drug, Ipsen's Cancer Drug - Nasdaq

Moderna’s reset hinges on oncology - statnews.com

Rx Rundown: EveryOne Medicines, Atrium Therapeutics, Moderna and more - Medical Marketing and Media

mRNA Therapeutics Market Booming with Rapid Growth Through 2033 | Moderna • BioNTech • CureVac • Pfizer - openPR.com

Warminster-Founded Arbutus Biopharma to Receive $190M in Moderna Settlement - BUCKSCO.Today

MRNA Shares Rally After Hours On Inking Settlement Deal Over Vaccine Patent Row - Stocktwits

Moderna Settles COVID-19 Vaccine Patent Litigation for $950M - Law.com

9 Biotech Stocks Trading Far Below Fair Value With Up to 250% Upside Potential

Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit - Pharmaceutical Technology

Moderna reaches agreement in COVID-19 intellectural property dispute - Delaware Business Now

Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement - FinancialContent

Mixed options sentiment in Moderna with shares down 2.28% - TipRanks

How Moderna Inc. (MRNA) Affects Rotational Strategy Timing - Stock Traders Daily

Moderna Resolves $950M Patent Battle Over COVID-19 Vaccine Tech—Find Out How It Impacts the Industry - Investing News Network

Moderna to Pay US$950 Million to Settle COVID-19 Vaccine Patent Dispute - Nasdaq

Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era - FinancialContent

Moderna inks billion-dollar deal to settle long-running Spikevax dispute - Life Sciences Intellectual Property Review

After flu vaccine hiccups, potential $2.25 billion settlement, where does Moderna go from here? - The Boston Globe

Moderna Stock Surges 16% Following Global Patent Litigation Settlement - TIKR.com

Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn - AOL.com

Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn - 24/7 Wall St.

Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn - Yahoo Finance

Moderna (MRNA) Reaches Settlement Agreement with Arbutus Biopharma and Genevant Sciences - GuruFocus

The Escalator: Seres Therapeutics, Bavarian Nordic, Moderna and more - Medical Marketing and Media

Moderna reaches $950 million settlement with Arbutus and Genevant over patent litigation - Investing.com

Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating - marketscreener.com

Moderna Reaches Major Patent Settlement on mRNA Vaccines - TipRanks

Moderna Vaccine Patent Deal Sets Up High-Stakes Immunity Appeal - Bloomberg Law News

Moderna settles for $2.25B in COVID-19 vaccine patent battle; when clinicians struggle with substance use; AI-powered CT scans could fast-track diagnoses – Morning Medical Update - Medical Economics

3/4/2026 S&P 500 Update - Winners: MRNA, COIN, APP - Losers: BF-B, RCL, ROK - S&P 500: 0.8% - Trefis

S&P 500 Movers | Winners: MRNA, COIN, APP | Losers: BF-B, RCL, ROK - Trefis

Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears - Yahoo Finance

Stock Movers: Broadcom, Coinbase, Moderna - Bloomberg.com

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute - IPWatchdog.com

Moderna Settles Lipid Nanoparticle Patent-Infringement Case With Genevant/Arbutus - Citeline News & Insights

Why Moderna (MRNA) Stock Is Trading Up Today - The Globe and Mail

Why Moderna (MRNA) Stock Is Trading Up Today - Finviz

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology - MedCity News

U.S. Indexes Rose Wednesday; Moderna Topped Leaders - Barron's

Stock Movers: Abercrombie, Wix, Moderna - Bloomberg

Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement - Investor's Business Daily

The Sun Will Shine On Moderna Again - Initiating With A Buy (NASDAQ:MRNA) - Seeking Alpha

Moderna-Arbutus-Genevant Patent Settlement: Wall Street Says Not Best-Case Scenario But Removes Overhang For MRNA Stock - Stocktwits

Moderna shares rise on $2.25-billion settlement over COVID-19 vaccine technology - The Globe and Mail

Moderna Settles a Covid Vaccine Patent Lawsuit. What It Means for the Stock. - Barron's

Moderna reaches vaccine settlement, GitLab's guidance disappoints - Yahoo Finance

Here's Arbutus Biopharma's share of $950M Moderna settlement - The Business Journals

Moderna+agrees+to+pay+up+to+%242.25B+to+settle+COVID+vaccine+patent+dispute - Virginia Lawyers Weekly

Moderna to pay up to $2.25B to end mRNA vaccine patent fight - BioPharma Dive

What do you think about ABUS??

Stock Movers: Moderna, Abercrombie & Finch, and Brown-Forman - Bloomberg

Moderna rises on settlement, clearing vaccine patent dispute overhang - businessinsurance.com

Why Moderna’s $950M Patent Bill Is A Small Price For Pipeline Freedom (NASDAQ:MRNA) - Seeking Alpha

Moderna, Arbutus settle covid jab dispute - IAM Patent

Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus - Fierce Pharma

Stock Movers: Abercrombie & Finch, Tesla, and Moderna - Bloomberg

Moderna settles patent lawsuits over COVID vaccine for $950 million - WBUR

Chardan reiterates Arbutus Biopharma stock rating on Moderna deal - Investing.com

Moderna to pay $950M to settle vaccine litigation with Arbutus, Genevant - FirstWord Pharma

Why Is Moderna (MRNA) Stock Rising Today? $2.25B Patent Settlement - Tokenist

Moderna (MRNA) Settlement Reduces Legal Risks but Leaves Financi - GuruFocus

Moderna and Ross Stores Lead Stock Gainers on Wednesday - AOL.com

Moderna to Pay About $1 Billion to Settle Arbutus Litigation - Bloomberg.com

Moderna litigation outcome ‘favorable,’ but leaves some risk, says BofA - TipRanks

Moderna Just Settled a Lawsuit. What It Means for the Stock. - Barron's

THE BIGGEST MOVERS TODAY, AFTER EVERYONE WENT THROUGH COVID-19 , THE US-IRAN SEEMS LIKE DROP IN THE OCEAN TODAY

Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna -- WSJ - 富途牛牛

Moderna Stock Jumps 10% After $2.25B Patent Settlement Deal - Fine Day 102.3

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang - Yahoo Finance

MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS - Zacks Investment Research

Pharmalittle: We're reading about Moderna's $2.25 billion settlement, FDA warning letters, and more - statnews.com

Moderna gains as Arbutus/ Genevant settlement removes major financial risk - Seeking Alpha

MSTR, CRWD, MRNA, GTLB On Traders' Radar Today — Dow Futures Edge Higher As Investors Look Past Middle East Conflict - Stocktwits

Moderna Resolves Worldwide Arbutus/Genevant Litigation - Contract Pharma

Moderna settles patent dispute over COVID vaccines - medwatch.com

Morning Movers: Moderna rises after entering COVID settlement agreement - TipRanks

Moderna (MRNA) Settles COVID-19 Vaccine IP Dispute with Roivant Sciences - GuruFocus

Moderna and Ross Stores Lead Stock Gainers on Wednesday - 24/7 Wall St.

Moderna and Ross Stores Lead Stock Gainers on Wednesday - Yahoo Finance

Moderna to pay $950m to end litigation - marketscreener.com

Moderna shares jump as settlement removes major legal overhang - Investing.com

Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang - Reuters

Why Is Moderna (MRNA) Stock Surging Today, 3/4/26? - TipRanks

Moderna agrees $950m settlement of mRNA jab litigation - pharmaphorum

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars - Benzinga

Moderna settlement removes share overhang, says Citi - TipRanks

Moderna to pay up to $2.25B to settle COVID-19 patents case - bioworld.com

CrowdStrike, Nvidia and Moderna rise premarket; Abercrombie & Fitch falls - Investing.com

Is Moderna Stock Outperforming the Dow? - Barchart.com

Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant - BioSpace

Stocks making the biggest moves premarket: Moderna, Ross Stores, Box, Gitlab and more - CNBC

All the market moving news from premarket summarised in one short report 04/03

Arbutus Biopharma (ABUS) Reaches Settlement with Moderna Over Pa - GuruFocus

S&P 500 Futures Steady in Premarket Trading; Moderna, SSR Mining Lead - Barron's

Moderna stock rallies after patent settlement removes overhang - Invezz

Moderna Stock Pre-Market (+8.4%): Patent Litigation Settlement Reached - Trefis

These Stocks Are Today’s Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and More - Barron's

Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement - TipRanks

Bitcoin Surge Powers Crypto Stocks Higher as Moderna (MRNA) Resolves $950M Patent Dispute - parameter.io

Market Highlights: Bitcoin Surge Powers Crypto Stocks While Moderna (MRNA) Resolves Patent Dispute - Blockonomi

Moderna (MRNA) Reaches $2.3 Billion Settlement with Arbutus - GuruFocus

Moderna: Legal Overhang Eased but Valuation, Cash Headwinds and Respiratory Concentration Justify Neutral Stance - TipRanks

Shares jump as Moderna settles Covid vaccine dispute - Sharecast.com

Moderna, GitLab, Coinbase, Strategy, Broadcom, and More Stock Market Movers - Barron's

Genevant and Arbutus agree $2.25 billion global settlement with Moderna - The Pharma Letter

Moderna settles COVID vaccine patent dispute for up to $2.25 billion - Investing.com

Moderna And Genevant/Arbutus Settle LNP Patent Dispute For $950m+ - Citeline News & Insights

Moderna to pay up to $2.25B to settle COVID vaccine patent matter - Proactive financial news

Moderna jumps after settling Covid vaccine patent dispute - Sherwood News

Moderna (MRNA) Stock Rallies on $950 Million Patent Settlement - CoinCentral

Trending tickers: CrowdStrike, Moderna, Adidas, Vistry and Barratt Redrow - Yahoo Finance UK

Is Moderna (MRNA) Now Priced Attractively After Its Recent Share Price Surge - simplywall.st

Moderna to Pay Up to $2.25B to Settle COVID Vaccine Patent Dispute - National Today

MRNA Stock: Hold or Buy After Moderna's $950M Settlement? - EBC Financial Group

EMA Recommends Authorization for Moderna’s Flu–COVID Combination Vaccine - Contagion Live

Moderna To Pay At Least $950M To End COVID-19 Vax IP Fight - Law360

CRWD, MOBX, MU, TGT, MRNA: 5 Trending Stocks Today - CrowdStrike Holdings (NASDAQ:CRWD) - Benzinga

ABUS Settlement From Lawsuit with Moderna!

Moderna to pay Genevant Sciences and Arbutus Biopharma up to $2.25 billion in global patent settlement - PharmaLive

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant - WSJ

Jefferies reiterates Moderna stock Hold rating after patent deal - Investing.com

ROIV: $2.25B settlement with Moderna resolves all LNP patent disputes and enables major share repurchase - TradingView

Moderna to pay $950M to settle dispute with Bucks County's Arbutus Biopharma - The Business Journals

Moderna (MRNA) Surges 10% After Settling Patent Dispute - GuruFocus

Moderna agrees to pay nearly $1B to settle COVID vaccine battle - NBC Boston

Moderna agrees to pay nearly $1B to settle Covid vaccine patent battle - The Business Journals

Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline - MarketWatch

After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more - Investing.com

Moderna surges after hours on patent settlement with Arbutus and Genevant (MRNA:NASDAQ) - Seeking Alpha

Moderna (MRNA) Resolves Global Disputes with Arbutus and Genevan - GuruFocus

Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines - statnews.com

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute By Reuters - Investing.com

Moderna +10% after-hours as Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute - TradingView

Roivant, Arbutus Biopharma stocks surges on $2.25B Moderna settlement - Investing.com

Moderna Resolves Global Patent Litigation with Arbutus/Genevant - ACCESS Newswire

Arbutus Biopharma (Nasdaq: ABUS) details $2.25B Moderna patent settlement - Stock Titan

$2.25 billion Moderna deal ends COVID vaccine patent fight - Stock Titan

Moderna to pay $950M to end vaccine patent battle, avoid royalties - Stock Titan

Roivant unit lands up to $2.25B in Moderna COVID vaccine patent deal - Stock Titan

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna - GlobeNewswire

Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna - Yahoo Finance

Key facts: Moderna's stock up 70%; cancer vaccine shows promise; growth expected - TradingView

MRNA: Robust COVID vaccine sales and pipeline progress set the stage for diversified future growth - TradingView

Selling pressure pushes Moderna lower in today trading - Traders Union

Cambridge-based Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines - The Boston Globe

Moderately bullish activity in Moderna with shares down 7.15% - TipRanks

Analysts Are Bullish on These Healthcare Stocks: Nyxoah (NYXH), Moderna (MRNA) - The Globe and Mail

Should You Listen to Billionaires to Buy Moderna Stock in 2026? - TradingKey

I took 547 stock recommendations from r/ValueInvesting and had AI grade every single one

Moderna’s dual Covid-flu vaccine poised for EMA approval on positive CHMP take - Pharmaceutical Technology

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0 - Yahoo Finance UK

Moderna Stock (MRNA): Is It a Buy Now? 7 Questions After the Crash - InvestorPlace

Notable Monday Option Activity: IBM, FLNG, MRNA - Nasdaq

BMO (BERZ) $1.28M Autocallable Notes Linked to Moderna (MRNA) - Stock Titan